Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast Cancer.

待确认 20 由达姆发布于 2026/2/10 15:31:55

DOI:10.1158/2159-8290.CD-25-2102
作者：Tess A O'Meara,?Paolo Tarantino
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：In this issue of Cancer Discovery, Chen and colleagues demonstrate that, in preclinical models, HER2 expression level directly affects trastuzumab deruxtecan internalization and cytotoxicity

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

9小时前

帝企鹅

202602101721203778501.pdf

11小时前

Book学术机器人

2026/2/10 15:31:55 未找到该文献，机器人已退出，请等待人工下载

2026/2/10 15:31:55 Book学术AI机器人收到请求，开始寻找文献

2026/2/10 15:31:55 已向机器人发送请求

11小时前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Decoding inflammatory mediators in the Correa's cascade: From chronic gastritis to carcinogenesis and targeted therapies